Key Insights of Infectious Disease Diagnostics Market to 2022 Driven by (Hepatitis, HIV, HAI, HPV, TB, Influenza) Disease Types
Global infectious disease diagnostics market valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. Base year considered for study is 2016, & forecast for market size is provided for period between 2017 an
(EMAILWIRE.COM, September 20, 2018 ) Infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out.
Download Sample Papers of Infectious Disease Diagnostics Market spread across 170 Pages, Profiling 12 Companies and Supported with 85 Tables and 35 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=323163 .
The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches& approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
Key Stakeholders
• Orthodontic product manufacturers, vendors, and distributors
• Venture capitalists and other government funding organizations
• Healthcare service providers (including hospitals and dental & orthodontic clinics)
• Research laboratories
• Academic institutes
• Market research and consultancy firms
• Government and independent regulatory authorities
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=323163 .
Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.
Competitive Landscape
1 Market Overview
2 Market Ranking Analysis, 2017
3 Competitive Situation and Trends
4 Product Launches and Approvals
5 Collaborations, Agreements, and Partnerships
6 Acquisitions
7 Expansions
Discount and More Information “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at http://www.reportsnreports.com/contacts/discount.aspx?name=323163 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market. Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.
Download Sample Papers of Infectious Disease Diagnostics Market spread across 170 Pages, Profiling 12 Companies and Supported with 85 Tables and 35 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=323163 .
The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches& approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
Key Stakeholders
• Orthodontic product manufacturers, vendors, and distributors
• Venture capitalists and other government funding organizations
• Healthcare service providers (including hospitals and dental & orthodontic clinics)
• Research laboratories
• Academic institutes
• Market research and consultancy firms
• Government and independent regulatory authorities
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=323163 .
Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.
Competitive Landscape
1 Market Overview
2 Market Ranking Analysis, 2017
3 Competitive Situation and Trends
4 Product Launches and Approvals
5 Collaborations, Agreements, and Partnerships
6 Acquisitions
7 Expansions
Discount and More Information “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at http://www.reportsnreports.com/contacts/discount.aspx?name=323163 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market. Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.
Contact Information:
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results